Parasites, Hosts and Diseases

The Korea Society for Parasitology and Tropical Medicine (대한기생충학·열대의학회)
권호 표지
DOI QR코드

DOI QR Code

The Effect of ABO Blood Groups, Hemoglobinopathy, and Heme Oxygenase-1 Polymorphisms on Malaria Susceptibility and Severity

  • Received : 2017.11.12
  • Accepted : 2018.04.10
  • Published : 2018.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Malaria is one of the most important public health problems in tropical areas on the globe. Several factors are associated with susceptibility to malaria and disease severity, including innate immunity such as blood group, hemoglobinopathy, and heme oxygenase-1 (HO-1) polymorphisms. This study was carried out to investigate association among ABO blood group, thalassemia types and HO-1 polymorphisms in malaria. The malarial blood samples were collected from patients along the Thai-Myanmar border. Determination of ABO blood group, thalassemia variants, and HO-1 polymorphisms were performed using agglutination test, low pressure liquid chromatography and polymerase chain reaction, respectively. Plasmodium vivax was the major infected malaria species in the study samples. Distribution of ABO blood type in the malaria-infected samples was similar to that in healthy subjects, of which blood type O being most prevalent. Association between blood group A and decreased risk of severe malaria was significant. Six thalassemia types (30%) were detected, i.e., hemoglobin E (HbE), ${\beta}$-thalassemia, ${\alpha}$-thalassemia 1, ${\alpha}$-thalassemia 2, HbE with ${\alpha}$-thalassemia 2, and ${\beta}$-thalassemia with ${\alpha}$-thalassemia 2. Malaria infected samples without thalassemia showed significantly higher risk to severe malaria. The prevalence of HO-1 polymorphisms, S/S, S/L and L/L were 25, 62, and 13%, respectively. Further study with larger sample size is required to confirm the impact of these 3 host genetic factors in malaria patients.

Keywords

References

  1. Stevenson M, Riley M. Innate immunity to malaria. Nat Rev Immunol 2004; 4: 169-180. https://doi.org/10.1038/nri1311
  2. Weatherall DJ. Thalassaemia and malaria, revisited. Ann Trop Med Parasitol 1997; 91: 885-890. https://doi.org/10.1080/00034983.1997.11813215
  3. Takeda M, Kikuchi M, Ubalee R, Na-Bangchang K, Ruangweerayut R, Shibahara S, Imai S. Hirayama K. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to cerebral malaria in Myanmar. Jpn J Infect Dis 2005; 58: 268-271.
  4. Kuesap J, Hirayama K, Kikuchi M, Ruangweerayut R, Na-Bangchang K. Study on association between genetic polymorphisms of haem oxygenase-1, tumour necrosis factor, cadmium exposure and malaria pathogenicity and severity. Malar J 2010; 9: 260. https://doi.org/10.1186/1475-2875-9-260
  5. Campino S, Kwiatkowski D, Dessein A. Mendelian and complex genetics of susceptibility and resistance to parasitic infections. Semin Immunol 2006; 18: 411-422. https://doi.org/10.1016/j.smim.2006.07.011
  6. Allison AC. Protection afforded by sickle cell trait against subtertian malarial infection. Br Med J 1954; 1: 290-294. https://doi.org/10.1136/bmj.1.4857.290
  7. Martin SK, Miller LH, Hicks CU, David-West A, Ugbode C, Deane M. Frequency of blood group antigens in Nigerian children with falciparum malaria. Trans R Soc Trop Med Hyg 1979; 73: 216-318. https://doi.org/10.1016/0035-9203(79)90217-7
  8. Fischer PR, Boone P. Short report: severe malaria associated with blood group. Am J Trop Med Hyg 1998; 58: 122-123. https://doi.org/10.4269/ajtmh.1998.58.122
  9. Lell B, May J, Schmidt-Ott RJ, Lehman LG, Luckner D, Greve B, Matousek P, Schmid D, Herbich K, Mockenhaupt FP, Meyer CG, Bienzle U, Kremsner PG. The role of red blood cell polymorphisms in resistance and susceptibility to malaria. Clin Infect Dis 1999; 28: 794-799. https://doi.org/10.1086/515193
  10. Tekeste Z, Petros B. The ABO blood group and Plasmodium falciparum malaria in Awash, Metehara and Ziway areas, Ethiopia. Malar J 2010; 9: 280. https://doi.org/10.1186/1475-2875-9-280
  11. Pathirana SL, Alles HK, Bandara S, Phone-Kyaw M, Perera MK, Wickremasinghe AR, Mendis KN, Handunnetti SM. ABO-bloodgroup types and protection against severe, Plasmodium falciparum malaria. Ann Trop Med Parasitol 2005; 99: 119-124. https://doi.org/10.1179/136485905X19946
  12. Rowe JA, Handel IG, Thera MA, Deans AM, Lyke KE, Kone A, Diallo DA, Raza A, Kai O, Marsh K, Plowe CV, Doumbo OK, Moulds JM. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proc Natl Acad Sci USA 2007; 104: 17471-17476. https://doi.org/10.1073/pnas.0705390104
  13. Panda AK, Panda SK, Sahu AN, Tripathy R, Ravindran B, Das BK. Association of ABO blood group with severe falciparum malaria in adults: case control study and meta-analysis. Malar J 2011; 10: 309. https://doi.org/10.1186/1475-2875-10-309
  14. Rout R, Dhangadamajhi G, Ghadei M, Mohapatra BN, Kar SK, Ranjit M. Blood group phenotypes A and B are risk factors for cerebral malaria in Odisha, India. Trans R Soc Trop Med Hyg 2012; 106: 538-543. https://doi.org/10.1016/j.trstmh.2012.05.014
  15. Resende SS, Milagres VG, Chaves DG, Fontes CJF, Carvalho LH, Sousa TN, Brito CFA. Increased susceptibility of blood type O individuals to develop anemia in Plasmodium vivax infection. Infect Genet Evol 2017; 50: 87-92. https://doi.org/10.1016/j.meegid.2017.03.001
  16. Vento S, Cainelli F, Cesario F. Infections and thalassaemia. Lancet Infect Dis 2006; 6: 226-233. https://doi.org/10.1016/S1473-3099(06)70437-6
  17. Chotivanich K, Udomsangpetch R, Pattanapanyasat K, Chierakul W, Simpson J, Looareesuwan S, White N. Hemoglobin E: a balanced polymorphism protective against high parasitemias and thus severe P. falciparum malaria. Blood 2002; 100: 1172-1176.
  18. Wambua S, Mwangi TW, Kortok M, Uyoga SM, Macharia AW, Mwacharo JK, Weatherall DJ, Snow RW, Marsh K, Williams TN. The effect of alpha+-thalassaemia on the incidence of malaria and other diseases in children living on the coast of Kenya. PLoS Med 2006; 3: 643-651.
  19. Pasvol G, Weatherall DJ, Wilson RJ, Smith DH, Gilles HM. Fetal haemoglobin and malaria. Lancet 1976; 1: 1269-1272.
  20. Pantaleo A, Ferru E, Carta F, Valente E, Pippia P, Turrini F. Effect of heterozygous beta thalassemia on the phosphorylative response to Plasmodium falciparum infection. J Proteomics 2012; 76: 251-258. https://doi.org/10.1016/j.jprot.2012.08.018
  21. Walther M, De Caul A, Aka P, Njie M, Amambua-Ngwa A, Walther B, Predazzi IM, Cunnington A, Deininger S, Takem EN, Ebonyi A, Weis S, Walton R, Rowland-Jones S, Sirugo G, Williams SM, Conway DJ. HMOX1 gene promoter alleles and high HO-1 levels are associated with severe malaria in Gambian children. PLoS Pathog 2012; 8: e1002579. https://doi.org/10.1371/journal.ppat.1002579
  22. Clark IA, Awburn MM, Harper CG, Liomba NG, Molyneux ME. Induction of HO-1 in tissue macrophages and monocytes in fatal falciparum malaria and sepsis. Malar J 2003; 2: 41. https://doi.org/10.1186/1475-2875-2-41
  23. Sambo MR, Trovoada MJ, Benchimol C, Quinhentos V, Goncalves L, Velosa R, Marques MI, Sepulveda N, Clark TG, Mustafa S, Wagner O, Coutinho A, Penha-Goncalves C. Transforming growth factor beta 2 and heme oxygenase 1 genes are risk factors for the cerebral malaria syndrome in Angolan children. PLoS One 2010; 5: e11141. https://doi.org/10.1371/journal.pone.0011141
  24. Shibahara S. The heme oxygenase dilemma in cellular homeostasis: new insights for the feedback regulation of heme catabolism. Tohoku J Exp Med 2003, 200: 167-186. https://doi.org/10.1620/tjem.200.167
  25. Fucharoen S, Winichagoon P. Thalassemia and abnormal haemoglobin. Int J Hematol 2002: 76 (suppl): 83-89. https://doi.org/10.1007/BF03165094
  26. Nagel RL, Raventos-Suarez C, Febby ME, Tonowitz H, Sicard D, Labie D. Impairment of the growth of P. falciparum in HbEE erythrocytes. J Clin Invest 1981; 68: 303-305. https://doi.org/10.1172/JCI110248
  27. World Health Organization. Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. Geneva, Switzerland. World Health Organization. 2011.
  28. World Health Organization. Guidelines for the Treatment of Malaria. 2nd ed. Geneva, Switzerland. World Health Organization. 2010, p 35.
  29. Fu WP, Zhao ZH, Fang LZ, Sun C, Liu L, Zhang JQ, Zhang YP, Dai LM. Heme oxygenase-1 polymorphism associated with severity of chronic obstructive pulmonary disease. Chin Med J 2007; 120: 12-16.
  30. Chandanayingyong D, Sasaki TT, Greenwalt TJ. Blood groups of the Thais. Transfusion 1967; 7: 269-276. https://doi.org/10.1111/j.1537-2995.1967.tb05516.x
  31. Nathalang O, Kuvanont S, Punyaprasiddhi P, Tasaniyanonda C, Sriphaisal T. A preliminary study of the distribution of blood group systems in Thai blood donors determined by the gel test. Southeast Asian J Trop Med Public Health 2001; 32: 204-207.
  32. Palacajornsuk P, Somsak P. Screening of ABO, Rh typing and unexpected alloantibodies in pregnant women attending antenatal care at Sriphat Medical Center, Faculty of Medicine, Chiang Mai University. J Assoc Med Sci 2017; 50: 153-158 (in Thai).
  33. Fucharoen S, Winichagoon P. Hemoglobinopathies in Southeast Asia. Hemoglobin 1987; 11: 65-88. https://doi.org/10.3109/03630268709036587
  34. Shibahara S, Kitamuro T, Takahashi K. Heme degradation and human disease: diversity is the soul of life. Antioxid Redox Signal 2002; 4: 593-602. https://doi.org/10.1089/15230860260220094

Cited by

  1. Effects of IgG and IgM autoantibodies on non-infected erythrocytes is related to ABO blood group in Plasmodium vivax malaria and is associated with anemia vol.22, pp.8, 2018, https://doi.org/10.1016/j.micinf.2020.02.003
  2. There will be blood vol.22, pp.9, 2018, https://doi.org/10.1016/j.micinf.2020.04.008